Figure 1 Historical evolution of the clinical classification and

Slides:

Advertisements

Similar presentations

This lecture was conducted during the Nephrology Unit Grand Ground by Nephrology Registrar under Nephrology Division, Department of Medicine in King Saud.

Advertisements

ANTI-Ro/SSA 52 ANTIBODIES IN AUTOIMMUNE DISEASES Coordinator: Monica Copotoiu MD,PhD First author: Gabriela Mihai Coauthors: Isabela Micu, Mihaela Budianu,

Nomenclature and classification of rheumatic diseases INFLAMMATORY JOINT DISEASES Rheumatoid arthritis Diseases of connective tissue ( SLE, Antiphospholipid.

Autoantibodies associated with Rheumatic disease

From: Prevalence of Antineutrophil Cytoplasmic Antibodies in a Large Inception Cohort of Patients with Connective Tissue Disease Ann Intern Med. 1997;126(11):

Autoimmune Disorders During Pregnancy -Lupus -Antiphospholipid syndrome Rovnat Babazade, MD Obstetrical Anesthesia-2016.

“Mixed Connective Tissue Disease: Still Crazy After All These Years”

3. AUTOIMMUNITY Immune Mechanisms Tolerance 4. Rheumatologic diseases

Autoimmune disease in pregnancy

Copyright © 2004 American Medical Association. All rights reserved.

Figure 3 The induction of anti-DNA antibodies by bacterial DNA

Figure 1 Lymphocytes during the disease

Nat. Rev. Cardiol. doi: /nrcardio

Figure 3 Example of how a noncoding regulatory rheumatoid

Figure 5 Involvement of B cells in SLE

Figure 2 A timeline summarizing the development of diagnostic tools in rheumatology Figure 2 | A timeline summarizing the development of diagnostic tools.

Figure 1 Rheumatoid arthritis development over time in relation to the level of inflammation Figure 1 | Rheumatoid arthritis development over time in relation.

Nat. Rev. Rheumatol. doi: /nrrheum

Nat. Rev. Rheumatol. doi: /nrrheum

Nat. Rev. Rheumatol. doi: /nrrheum

Figure 1 Factors underlying metabolic alterations in osteoarthritis

Subjects gain SLE classification through Systemic Lupus International Collaborating Clinics (SLICC) criteria of low complement, immunological manifestations.

Figure 2 Heat map of targeted therapies in autoimmune diseases

Nat. Rev. Rheumatol. doi: /nrrheum

Figure 1 Organs involved in coeliac-disease-associated autoimmunity

Figure 2 Targeted versus untargeted metabolomics approaches

Figure 1 Metabolic profiling as a tool for studying rheumatic diseases

Figure 4 Antinuclear antibodies and disease activity in SLE

Volume 93, Issue 1, Pages (January 2018)

Figure 3 Transcriptome studies performed in the target

Figure 2 Shared genetic loci in systemic autoimmune diseases

Figure 7 Defects in apoptosis

Figure 3 Nucleic acid sensors in SLE

Figure 1 Location of HLA variants known to be associated

A 61-Year-Old Man With Membranoproliferative Glomerulonephritis

Nat. Rev. Rheumatol. doi: /nrrheum

Nat. Rev. Rheumatol. doi: /nrrheum

Figure 3 Strategies to achieve therapeutic inhibition of IL-1

Figure 4 Approaches to targeting inhibitory immune receptors

Figure 2 Overlap of associated loci among five rheumatic diseases

Figure 2 Interaction effects between heterozygous HLA‑DRB1

Nat. Rev. Rheumatol. doi: /nrrheum

Nat. Rev. Rheumatol. doi: /nrrheum

Figure 3 Statistical approaches for the analysis of metabolomic data

Nat. Rev. Rheumatol. doi: /nrrheum

Figure 3 Multi-hit model for autoimmune diseases

Main fields of interest.

Nat. Rev. Rheumatol. doi: /nrrheum

Nat. Rev. Rheumatol. doi: /nrrheum

Nat. Rev. Rheumatol. doi: /nrrheum

Nat. Rev. Rheumatol. doi: /nrrheum

Figure 1 Treat to target, remission and low disease activity in SLE

Figure 1 The current model of the pathogenesis of SLE

Nat. Rev. Rheumatol. doi: /nrrheum

Figure 1 Reproductive health in patients with rheumatic diseases

Figure 1 Principles for the diagnosis and management of osteoarthritis

Mean Safety of Estrogens in Lupus Erythematosus National Assessment–Systemic Lupus Erythematosus Disease Activity Index (SELENA-SLEDAI) score at the last.

Nat. Rev. Rheumatol. doi: /nrrheum

Nat. Rev. Rheumatol. doi: /nrrheum

Nat. Rev. Cardiol. doi: /nrcardio

Figure 1 Chronic inflammation and DNA damage in people with SLE

Figure 1 Patterns of joint and organ involvement in rheumatic disease

Nat. Rev. Rheumatol. doi: /nrrheum

Figure 2 The main effects of adipokines on bone remodelling in osteoarthritis Figure 2 | The main effects of adipokines on bone remodelling in osteoarthritis.

Performance characteristics for multivariate assay SLE panel.

Systemic autoimmune diseases, such as systemic lupus erythematosus (SLE), rheumatoid arthritis (RA) and systemic sclerosis (SSc) cause immune-mediated.

Heterogeneity of TCRβ repertoire in autoimmune diseases.

Nat. Rev. Rheumatol. doi: /nrrheum

Anti-CarALB antibody prevalence and levels in RA and other CTD

Presentation transcript:

Figure 1 Historical evolution of the clinical classification and diagnostic criteria for systemic autoimmune diseases Figure 1 | Historical evolution of the clinical classification and diagnostic criteria for systemic autoimmune diseases. Classification and diagnostic criteria for various systemic autoimmune diseases including mixed connective tissue disease (MCTD), primary antiphospholipid syndrome (APS), rheumatoid arthritis (RA), Sjögren syndrome, systemic lupus erythematosus (SLE) and systemic sclerosis (SSc) have been developed, updated and refined over time. Detailed information on the criteria can also be found in Supplementary information S1 (figure). The information shown in these figures is to merely inform about the clinical criteria used for the diagnosis or classification of these diseases; further information on how to apply the criteria can be found in the original references. ARA, American Rheumatism Association; SICCA, Sjögren's International Collaborative Clinical Alliance; SLICC, Systemic Lupus International Collaborating Clinics. Barturen, G. et al. (2018) Moving towards a molecular taxonomy of autoimmune rheumatic diseases Nat. Rev. Rheumatol. doi:10.1038/nrrheum.2017.220